120 related articles for article (PubMed ID: 15542180)
61. Delivery of
Badami GD; La Manna MP; Di Carlo P; Stanek O; Linhartova I; Caccamo N; Sebo P; Dieli F
Front Immunol; 2023; 14():1289212. PubMed ID: 38106407
[TBL] [Abstract][Full Text] [Related]
62. Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells.
Adkins I; Kamanova J; Kocourkova A; Svedova M; Tomala J; Janova H; Masin J; Chladkova B; Bumba L; Kovar M; Ross PJ; Tuckova L; Spisek R; Mills KH; Sebo P
PLoS One; 2014; 9(8):e104064. PubMed ID: 25084094
[TBL] [Abstract][Full Text] [Related]
63. Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase.
Loucká J; Schlecht G; Vodolánová J; Leclerc C; Sebo P
Infect Immun; 2002 Feb; 70(2):1002-5. PubMed ID: 11796640
[TBL] [Abstract][Full Text] [Related]
64. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes.
Basler M; Masin J; Osicka R; Sebo P
Infect Immun; 2006 Apr; 74(4):2207-14. PubMed ID: 16552051
[TBL] [Abstract][Full Text] [Related]
65. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.
Wang X; Gray MC; Hewlett EL; Maynard JA
J Biol Chem; 2015 Feb; 290(6):3576-91. PubMed ID: 25505186
[TBL] [Abstract][Full Text] [Related]
66. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins.
Gmira S; Karimova G; Ladant D
Res Microbiol; 2001 Dec; 152(10):889-900. PubMed ID: 11766964
[TBL] [Abstract][Full Text] [Related]
67. Bioengineering of
Ladant D
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260
[TBL] [Abstract][Full Text] [Related]
68. Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo.
Wang P; Dong S; Zhao P; He X; Chen M
Biomaterials; 2018 Nov; 182():92-103. PubMed ID: 30107273
[TBL] [Abstract][Full Text] [Related]
69. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
Hormozi K; Parton R; Coote J
Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
[TBL] [Abstract][Full Text] [Related]
70. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways.
Fedele G; Spensieri F; Palazzo R; Nasso M; Cheung GY; Coote JG; Ausiello CM
PLoS One; 2010 Jan; 5(1):e8734. PubMed ID: 20090944
[TBL] [Abstract][Full Text] [Related]
71. Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen.
Malik AA; Imtong C; Sookrung N; Katzenmeier G; Chaicumpa W; Angsuthanasombat C
Toxins (Basel); 2016 Apr; 8(4):99. PubMed ID: 27043627
[TBL] [Abstract][Full Text] [Related]
72. Channel formation in model membranes by the adenylate cyclase toxin of Bordetella pertussis: effect of calcium.
Knapp O; Maier E; Polleichtner G; Masín J; Sebo P; Benz R
Biochemistry; 2003 Jul; 42(26):8077-84. PubMed ID: 12834359
[TBL] [Abstract][Full Text] [Related]
73. Adenylate cyclase toxin-mediated delivery of the S1 subunit of pertussis toxin into mammalian cells.
Iwaki M; Konda T
Pathog Dis; 2016 Feb; 74(1):ftv110. PubMed ID: 26607401
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of the toxicity of recombinant Bordetella pertussis adenylate cyclase toxin preparations.
Prior S; Xing DK; Auda G; Corbel MJ
Dev Biol (Basel); 2002; 111():117-27. PubMed ID: 12678231
[No Abstract] [Full Text] [Related]
75. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.
Guermonprez P; Fayolle C; Karimova G; Ullmann A; Leclerc C; Ladant D
Methods Enzymol; 2000; 326():527-42. PubMed ID: 11036662
[No Abstract] [Full Text] [Related]
76. [Novel system for CTL regulation triggered by PIR].
Endo S; Nakamura A; Takai T
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1108-13. PubMed ID: 21089549
[No Abstract] [Full Text] [Related]
77. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.
Connell TG; Shey MS; Seldon R; Rangaka MX; van Cutsem G; Simsova M; Marcekova Z; Sebo P; Curtis N; Diwakar L; Meintjes GA; Leclerc C; Wilkinson RJ; Wilkinson KA
Clin Vaccine Immunol; 2007 Jul; 14(7):847-54. PubMed ID: 17522328
[TBL] [Abstract][Full Text] [Related]
78. Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.
Stenger RM; Meiring HD; Kuipers B; Poelen M; van Gaans-van den Brink JA; Boog CJ; de Jong AP; van Els CA
Clin Vaccine Immunol; 2014 May; 21(5):641-50. PubMed ID: 24599530
[TBL] [Abstract][Full Text] [Related]
79. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling.
Kamanova J; Kofronova O; Masin J; Genth H; Vojtova J; Linhartova I; Benada O; Just I; Sebo P
J Immunol; 2008 Oct; 181(8):5587-97. PubMed ID: 18832717
[TBL] [Abstract][Full Text] [Related]
80. Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes.
Suhrbier A
Expert Rev Vaccines; 2002 Aug; 1(2):207-13. PubMed ID: 12901559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
